- Home
- ELP vs CDTX Comparison
ELP vs CDTX Comparison
Compare ELP & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELP | CDTX |
|---|---|---|
| Founded | 1954 | 2012 |
| Country | Brazil | United States |
| Employees | N/A | 73 |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 6.9B |
| IPO Year | 1997 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ELP | CDTX |
|---|---|---|
| Price | $10.56 | $220.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $128.75 |
| AVG Volume (30 Days) | 322.8K | ★ 2.3M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $4,681,123,759.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.83 | N/A |
| P/E Ratio | $17.86 | ★ N/A |
| Revenue Growth | ★ 12.38 | N/A |
| 52 Week Low | $5.72 | $15.22 |
| 52 Week High | $11.23 | $221.20 |
Technical Indicators
Market Signals| Indicator | ELP | CDTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.37 | 85.72 |
| Support Level | $9.96 | $219.60 |
| Resistance Level | $11.13 | $220.78 |
| Average True Range (ATR) | 0.28 | 0.71 |
| MACD | -0.04 | -4.15 |
| Stochastic Oscillator | 54.27 | 42.12 |
Price Performance
Historical ComparisonAbout ELP Companhia Paranaense de Energia (COPEL)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.